Page last updated: 2024-10-27

gemfibrozil and Infarction, Middle Cerebral Artery

gemfibrozil has been researched along with Infarction, Middle Cerebral Artery in 1 studies

Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.

Research Excerpts

ExcerptRelevanceReference
"Pretreatment with gemfibrozil (30 mg/kg) for 7 days moderately but significantly reduced infarct size at 24 h after MCAO."1.35Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice. ( Guo, Q; Liu, X; Namura, S; Wang, G, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, Q1
Wang, G1
Liu, X1
Namura, S1

Other Studies

1 other study available for gemfibrozil and Infarction, Middle Cerebral Artery

ArticleYear
Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice.
    Brain research, 2009, Jul-07, Volume: 1279

    Topics: Animals; Aorta; Body Temperature; Brain; Cerebrovascular Circulation; Cholesterol; Gemfibrozil; Gene

2009